“Study of Lopinavir/Ritonavir in Severe COVID-19 Patients with Comorbid Hypertension and Diabetes Mellitus” (2022) Indian Journal of Forensic Medicine & Toxicology, 16(4), pp. 174–181. doi:10.37506/ijfmt.v16i4.18570.